Skip to main content

and
  1. No Access

    Article

    Prevalence and clinical significance of ANCA positivity in lupus nephritis: a case series of 116 patients and literature review

    The prevalence and clinical significance of anti-neutrophil cytoplasmic antibodies [ANCAs] in patients with lupus nephritis [LN] is not fully elucidated. Our aim was to determine whether LN patients with ANCA ...

    Rosanna Lacetera, Marta Calatroni, Letizia Roggero in Journal of Nephrology (2023)

  2. No Access

    Article

    Belimumab may decrease flare rate and allow glucocorticoid withdrawal in lupus nephritis (including dialysis and transplanted patient)

    Belimumab (Benlysta) is currently approved for the treatment of active Lupus despite standard therapy. Few data are available on the efficacy of this drug in lupus nephritis (LN).

    Valentina Binda, Barbara Trezzi, Nicoletta Del Papa in Journal of Nephrology (2020)